Medically reviewed by Khadeja Haye, MD The human papillomavirus (HPV) vaccine is recommended for people ages 9 to 26. Most ...

For patients with human papillomavirus (HPV) type 16 (HPV16)-positive cervical intraepithelial neoplasia grade 3 (CI ...

Dr. M.G. Janaki, Consultant Radiation Oncologist at Ramaiah Memorial Hospital, shares her expertise on cervical cancer, its ...

With sedentary lifestyle choices you will only increase the chances of cervical problems and decrease your likelihood of ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published ...

Cervical cancer, the fourth most common cancer in women, is closely linked to persistent HPV infections. Early detection ...

Men and women between the ages of nine and 45 can get the vaccine but it is highly recommended to vaccinate children earlier ...

Of note, many patients remained in the cohort and were untested through this first round of surveillance (overall: 49.4%; ...